Tweet
Could ASPIRIN be the first over the counter treatment for coronavirus?
Hospitalized patients already taking the drug daily were 47% less likely to die of COVID-19
Covid-19 patients using aspirin were 43% less likely to be admitted to the ICU
They were also 44% less likely to need ventilators due to their heart medication
Daily aspirin use also reduced the risk of death by 47%
Researchers say aspirin could be the first over-the counter drug for Covid-19
By MARY KEKATOS SENIOR HEALTH REPORTER FOR DAILYMAIL.COM and VANESSA CHALMERS HEALTH REPORTER FOR MAILONLINE
PUBLISHED: 19:27 GMT, 26 October 2020 | UPDATED: 10:28 GMT, 27 October 2020
Taking aspirin could reduce the risk of hospitalized Covid-19 patients falling severely ill or dying, a new study suggests.
Researchers found a daily low-dose pill could lower the likelihood of being admitted to the ICU or being placed on a ventilator by more than 40 per cent. Additionally, it cut the risk of dying from the infection by nearly half, when compared to people who were not taking the medicine.
University of Maryland School of Medicine (UMSOM) experts say the findings provide 'cautious optimism' of using aspirin to help prevent severe complications caused by Covid-19.
The cheap over-the-counter drug, which can be bought in supermarkets and petrol stations, is used for relieving minor aches, pains, and fevers caused by headaches, periods, muscle injuries, cold and flu, and arthritis.
People also use it as a blood thinner to reduce the risk of heart attacks and strokes or manage heart conditions. Experts believe it may be aspirin's ability to prevent blood clotting that makes it beneficial in Covid-19, given the illness can cause 'sticky blood' which can lead to deadly blockages in arteries.
However, aspirin is classed as a non-steroidal anti-inflammatory drug (NSAID) — a group of medicines that have come under the spotlight during the pandemic over fears they may potentially make Covid-19 symptoms worse.
Some studies have claimed NSAIDs, which also include paracetamol and ibuprofen, could make hospitalised coronavirus patients more likely to die. But health chiefs insist there is 'no clear evidence' they pose a danger.
A new study from the University of Maryland School of Medicine found hospitalized coronavirus patients who took a low-dose daily aspirin were 43 per cent less likely to be admitted to the ICU and 44 per cent less likely to need ventilators (file image) +6
A new study from the University of Maryland School of Medicine found hospitalized coronavirus patients who took a low-dose daily aspirin were 43 per cent less likely to be admitted to the ICU and 44 per cent less likely to need ventilators (file image)
Daily aspirin use also reduced the risk of death from Covid-19 among hospitalized patients by 47%. Pictured: A Covid-19 patient lies at DHR Health, in McAllen, Texas, July 29 +6
Daily aspirin use also reduced the risk of death from Covid-19 among hospitalized patients by 47%. Pictured: A Covid-19 patient lies at DHR Health, in McAllen, Texas, July 29
The latest study only looked at the effects of aspirin, analysing data from people who were already taking the drug to manage their heart disease.
UMSOM researchers looked at the medical records of 412 Covid-19 patients treated at University of Maryland Medical Center in Baltimore and three other hospitals along the East Coast.
About a quarter of the participants were taking a daily low-dose aspirin (usually 80 milligrams) either before or just as they were admitted to hospital with the disease.
Covid-19 patients using aspirin were 43% less likely to be admitted to the ICU
They were also 44% less likely to need ventilators due to their heart medication
Daily aspirin use also reduced the risk of death by 47%
Researchers say aspirin could be the first over-the counter drug for Covid-19
By MARY KEKATOS SENIOR HEALTH REPORTER FOR DAILYMAIL.COM and VANESSA CHALMERS HEALTH REPORTER FOR MAILONLINE
PUBLISHED: 19:27 GMT, 26 October 2020 | UPDATED: 10:28 GMT, 27 October 2020
Taking aspirin could reduce the risk of hospitalized Covid-19 patients falling severely ill or dying, a new study suggests.
Researchers found a daily low-dose pill could lower the likelihood of being admitted to the ICU or being placed on a ventilator by more than 40 per cent. Additionally, it cut the risk of dying from the infection by nearly half, when compared to people who were not taking the medicine.
University of Maryland School of Medicine (UMSOM) experts say the findings provide 'cautious optimism' of using aspirin to help prevent severe complications caused by Covid-19.
The cheap over-the-counter drug, which can be bought in supermarkets and petrol stations, is used for relieving minor aches, pains, and fevers caused by headaches, periods, muscle injuries, cold and flu, and arthritis.
People also use it as a blood thinner to reduce the risk of heart attacks and strokes or manage heart conditions. Experts believe it may be aspirin's ability to prevent blood clotting that makes it beneficial in Covid-19, given the illness can cause 'sticky blood' which can lead to deadly blockages in arteries.
However, aspirin is classed as a non-steroidal anti-inflammatory drug (NSAID) — a group of medicines that have come under the spotlight during the pandemic over fears they may potentially make Covid-19 symptoms worse.
Some studies have claimed NSAIDs, which also include paracetamol and ibuprofen, could make hospitalised coronavirus patients more likely to die. But health chiefs insist there is 'no clear evidence' they pose a danger.
A new study from the University of Maryland School of Medicine found hospitalized coronavirus patients who took a low-dose daily aspirin were 43 per cent less likely to be admitted to the ICU and 44 per cent less likely to need ventilators (file image) +6
A new study from the University of Maryland School of Medicine found hospitalized coronavirus patients who took a low-dose daily aspirin were 43 per cent less likely to be admitted to the ICU and 44 per cent less likely to need ventilators (file image)
Daily aspirin use also reduced the risk of death from Covid-19 among hospitalized patients by 47%. Pictured: A Covid-19 patient lies at DHR Health, in McAllen, Texas, July 29 +6
Daily aspirin use also reduced the risk of death from Covid-19 among hospitalized patients by 47%. Pictured: A Covid-19 patient lies at DHR Health, in McAllen, Texas, July 29
The latest study only looked at the effects of aspirin, analysing data from people who were already taking the drug to manage their heart disease.
UMSOM researchers looked at the medical records of 412 Covid-19 patients treated at University of Maryland Medical Center in Baltimore and three other hospitals along the East Coast.
About a quarter of the participants were taking a daily low-dose aspirin (usually 80 milligrams) either before or just as they were admitted to hospital with the disease.
Commentaire